Motoshi Iwao, Ryota Tanaka, Yosuke Suzuki, Ryosuke Tatsuta, Takehiro Hashimoto, Kazufumi Hiramatsu, Hiroki Itoh. The active metabolite hydroxyitraconazole has substantially higher in vivo free fraction and free concentrations compared to itraconazole. Journal of pharmaceutical and biomedical analysis. 2025. 259. 116775-116775
Sho Saito, Aki Sakurai, Yasufumi Matsumura, Kohei Uemura, Ryota Hase, Hideaki Kato, Naoya Itoh, Takehiro Hashimoto, Takashi Matono, Jiefu Yu, et al. Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network. JAC-antimicrobial resistance. 2025. 7. 2. dlaf027
Nozomi Kondo, Ryota Tanaka, Ryosuke Tatsuta, Haruka Tsushita, Takehiro Hashimoto, Kazufumi Hiramatsu, Hiroki Itoh. Effect of Augmented Renal Clearance and Febrile Neutropenia on Initial Trough Level and Clearance of Teicoplanin. Therapeutic drug monitoring. 2025
Yoshihide Hioki, Takehiro Hashimoto, Kazufumi Hiramatsu, Kosaku Komiya. The Possibility of Ceftolozane/Tazobactam-Resistant Pseudomonas aeruginosa Emergence After Two Days of Antibiotic Therapy: A Case Report. Cureus. 2025. 17. 2. e79207
Takehiro Hashimoto, Akira Nishizono, Kazufumi Hiramatsu. A case report of pulmonary paragonimiasis diagnosed via the deterioration of pulmonary cavities during high-dose corticosteroid therapy for chronic eosinophilic pneumonia. Annals of thoracic medicine. 2025. 20. 1. 74-77